University of Miami Living Legends in Psychopharmacology 2026

Description

+ Include:  videos + file sub vtt, size:  GB

+ Target Audience: practicing clinicians in the field of psychopharmacology drawn from the following disciplines: psychiatry, medicine nurses and psychology

+ Sample video: contact me for sample video

+ Information:

Join world-renowned leaders in the field for a transformative two-day conference at the leading edge of psychiatric innovation. Living Legends in Psychopharmacology 2026 brings together pioneering minds to explore the frontiers of neuroscience, precision medicine, and AI – translating cutting-edge discoveries into real-world strategies for even the most complex, treatment-resistant cases.

Learning Objectives

• Apply principles of personalized psychiatry to optimize psychotropic medication regimens in treatment-resistant patients.
• Evaluate and implement evidence-based use of cutting-edge therapies.
• Integrate current neurobiological insights into the diagnosis and treatment planning of complex psychiatric conditions.
• Select and sequence appropriate pharmacologic and somatic treatments for major depressive disorder, schizophrenia, and bipolar disorder.
• Translate emerging clinical research into practical decision-making tools for the treatment of complex psychiatric cases.
• Formulate individualized treatment plans for anxiety disorders and PTSD.
• Design safe and effective psychopharmacologic treatment strategies for women across the reproductive lifespan.
• Interpret and apply recent findings in pediatric, adolescent, and geriatric psychiatry to inform age-appropriate diagnosis, medication selection, and monitoring strategies.
• Assess and treat autism spectrum disorders using advanced pharmacologic approaches.
• Diagnose and manage sleep disorders and substance use disorders with a focus on neurobiological mechanisms, risk mitigation, and integrated pharmacologic and behavioral treatments.
• Translate emerging clinical research into practical decision-making tools for the treatment of complex psychiatric cases.
• Demonstrate enhanced clinical communication and therapeutic alliance skills that support adherence, safety, and patient-centered care in psychopharmacologic practice.
• Analyze the ethical implications of integrating artificial intelligence in psychiatric care, focusing on data privacy, algorithmic biases, and the preservation of the therapeutic alliance, while identifying strategies to ensure that AI tools enhance, rather than replace, patient-centered care.

Target Audience

Practicing clinicians in the field of psychopharmacology drawn from the following disciplines: psychiatry, medicine, nursing, nurse practitioners, and psychology.

 

+ Topics:

• 01 New Vistas in the Treatment of Mood & Anxiety Disorders – Psychedelics, Neuromodulation and More
• 02 Young Brains Current Evidence and Innovations in Pediatric and Adolescent Psychopharmacology
• 03 Hormones and the Mind – Psychopharmacology Across the Female Reproductive Lifespan
• 04 Caring for the Aging Mind – Psychopharmacologic Approaches in Geriatric Psychiatry
• 05 Advances in Pharmacological Treatments in Serious Mental Illness – Decoding the Breadth of Treatment Effects With Accessible Digital Phenotyping
• 06 Beyond Behavior – Pharmacologic and Neurobiological Advances in Treating Autism Spectrum Disorder
• 07 From Mesmer to Psychedelics – Appreciating the Contributions of Contextual Factors to Treatment Response
• 08 Improving Outcomes in Treatment-Resistant Depression Through Personalized, Evidence-Based Strategies
• 08 Personalizing Psychopharmacology Through Genetics and Artificial Intelligence
• 09 From Synapse to Symptom to Disease – Nosology and Pathogenesis as the Foundation for Psychiatric Treatment
• 10 Depression Decoded – Inflammation, Neurocircuitry, and Breakthrough Treatments for Difficult-to-Treat Mood Disorders
• 11 Navigating the Future – Ethical Challenges and Considerations of Artificial Intelligence in Psychiatric Care
• 13 Restoring Rest – Neurobiological and Pharmacologic Strategies for Sleep Disorders in Psychiatric Practice
• 14 Dual Diagnosis in Focus – Treating Co-Occurring Psychiatric and Substance Use Disorders
• 15 The Risks and Benefits of Benzodiazepines – A Balanced Update